LAB vs MRVL · rev $174.4M vs P/E 100, rev $8.19B
Standard Biotools Inc (LAB) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported MRVL revenue for 2026-01-31 was $8.19B. Net income was $2.67B. Revenue was up 42.1% from 2025-02-01 to 2026-01-31. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
LAB currently screens at market cap $317.1M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the LAB and MRVL stock pages for the full models.
Not investment advice.